Authors/Disclosures
|
Timothy M. Miller, MD, PhD
(Washington University)
|
Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen IDEC. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. |
|
Masaki Kobayashi, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Richard A. Smith, MD
(Center for Neurologic Study)
|
Dr. Smith has received personal compensation for serving as an employee of Center for Neurologic Study. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Inventor with Ionis Pharmaceutical. |
|
Genevieve A. Laforet, MD, PhD
(Genzyme, a Sanofi Company)
|
No disclosure on file |
|
Koji Yamanaka, MD, PhD
(Research Institute of Environmental Medicine, Nagoya University)
|
No disclosure on file |
|
Celeste Di Johnson
|
No disclosure on file |
|
Brett Monia, PhD
(Ionis Pharmaceuticals)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Arvind Narayana
|
Arvind Narayana has received personal compensation for serving as an employee of Akcea Therapeutics. Arvind Narayana has received stock or an ownership interest from Akcea Therapeutics. |
|
|
No disclosure on file |
|
Emily Brereton
|
No disclosure on file |
|
DE Frank
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Don Cleveland, PhD
(Ludwig Institute)
|
No disclosure on file |